authors
- Hao, D
- Ellis, Peter
- Laurie, SA
- Juergens, Rosalyn
- Mates, M
- Bradbury, PA
- Tsao, M
- Tehfe, M
- Kollmannsberger, CK
- Goffin, John
- Wheatley-Price, P
- Hilton, J
- Robinson, AG
- Brown-Walker, P
- Tu, D
- Smoragiewicz, M
- Seymour, LK
Pharmacokinetic (PK) and updated survival data from the Canadian cancer trials group IND.226 study of durvalumab ± tremelimumab in combination with platinum-doublet chemotherapy
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- October 2019
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Annals of Oncology Journal